Warren urges FTC to probe Novo, Catalent deal

Taking stock of the drug industry, from the lab to the medicine chest

October 10, 2024 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Alex Wong/Getty Images STAT+ | Warren urges FTC to probe deal that would give Novo Nordisk control of some Catalent plants Critics say the would give Novo Nordisk an unfair advantage in the burgeoning market for drugs used to treat obesity and diabetes. By Ed Silverman STAT+ | Medical journal peer reviewers are paid millions by industry, study finds Peer reviewers may have industry ties due to their academic expertise, but conflict of interest disclosures are rare, the authors wrote. By Ed Silverman STAT+ | Frustrated telehealth providers say their businesses face 'doom and gloom' Telehealth providers prescribing controlled substances face chaos as pandemic-era flexibilities are set to end, with no new rules in sight. By Katie Palmer, Mohana Ravindranath, and Mario Aguilar Illustration: Christine Kao/STAT; photos: Getty images STAT+ | 10 people to watch who could shape health policy in a Harris administration Harris has advocated for reproductive health access and addressing maternal mortality disparities.  By Rachel Cohrs Zhang STAT+ | 7 children developed blood cancer after Bluebird Bio gene therapy for rare neurological disease Additional cancer cases create difficult choices for families facing a devastating neurological disorder with few alternative treatments.   By Jason Mast

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser